@prefix orcid: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" . sub:version prov:value "1"^^xsd:integer . rdf:object ns1:C0011008 "date"; ns1:C1547350 "date"; ns1:C1548309 "date"; ns1:C2348077 "date"; ns1:C2740799 "date" . rdf:predicate ns3:TRIPLE_UID:wu0iwj8x-TRIPLE-ABSTRACT-1 "show" . rdf:subject ns1:C0011777 "dexamethasone"; ns1:C4726677 "remdesivir" . rdfs:Triple-UID ns2:TRIPLE_UID:wu0iwj8x-TRIPLE-ABSTRACT-1 "wu0iwj8x-TRIPLE-ABSTRACT-1" . rdfs:sentence rdfs:label "To date, only dexamethasone and remdesivir have been shown to be effective, but several other promising candidates are in trials." . rdfs:triple rdfs:label "only dexamethasone and remdesivir shown To date" . } sub:provenance { sub:assertion prov:generatedAtTime "2021-07-25T21:45:36.473448"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "eGAhO/ykxft4Dtjp3WgFhq5Qb3o/cO524fiAoI/t4Qn+tDgI13AZX3ObT7C4tt2OmcnQXUA6CBU4xqnF3A6iegVeVWhb0Dso1hvVPVaOK1ueGkakToUQKqqje1JTNCfUI9w0/BxelibvyKKGdSRPWb0zfxze+gZUnSMsvg1kXNI="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-07-25T21:45:36.473448"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-8954-0470 . }